Alpelisib is a PI3K inhibitor targeting HR /HER2breast cancer patients with PIK3CA mutations. It’s meant to mess with PI3K signaling, which is a big deal in cancer growth. You can get this drug in three different strengths—50, 200, and 300 milligrams.
For adults, the suggested dose is 300 mg once a day, and it’s best taken with something to eat. These tablets have a film coating and they come in packs of 28 in those little blisters. They tell patients to keep taking Alpelisib until their cancer gets worse or something bad happens.
You gotta follow the dosing directions closely to get the most out of it and to keep risks down.
Reviews
There are no reviews yet.